First published · Last updated
QbD-driven RP-HPLC Method Development and Validation for Simultaneous Estimation of Iguratimod and Methotrexate in a Lipid-based Formulation
Journal article published by Springer Science and Business Media LLC describing QbD-driven RP-HPLC method development and validation for simultaneous estimation of iguratimod and methotrexate in a lipid-based formulation. Published 2026-05-16.
Categories: science-and-space
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 5/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 1/10
Why it matters
It presents a validated analytical method for simultaneous quantification of two drugs in a lipid-based formulation, which is relevant for formulation analysis and quality control.

